Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Therapeutics × Dermatologic × Clear all

Phase

Phase 2 6 Phase NA 4 Phase 3 3 Phase 4 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1 Dermatologic 1

Conditions

Carcinoma, Basal Cell 1

Interventions

Imiquimod 14 Aminolevulinic Acid 7 Diclofenac 6 3-ingenyl angelate 6 Fluorouracil 5 Cryotherapy 5 tirbanibulin 4 Sirolimus 4 Nivolumab 4 methyl 5-aminolevulinate 3 denileukin diftitox 3 aldesleukin 3 Photochemotherapy 3 Blood Specimen Collection 3 Vemurafenib 2 Tacrolimus 2 Prednisone 2 Ointments 2 Methotrexate 2 Ipilimumab 2 HhAntag691 2 Gels 2 Cyclosporine 2 Cryosurgery 2 trametinib 1 technetium-diethylenetriaminepentaacetic acid-mannosyl-dextran 1 technetium Tc 99m nanocolloid 1 sargramostim 1 relatlimab 1 prednylidene 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03610022 2022-08-18

OPTIVISMO-1

University Hospital, Bordeaux

Phase 4 Completed

Carcinoma, Basal Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡